Browse > Article

Postoperative Radiotherapy for Parotid Gland Malignancy  

Eom Keun-Yong (Departments of Radiation Oncology, Seoul National University College of Medicine)
Wu Hong-Gyun (Departments of Radiation Oncology, Institute on Radiation Medicine, Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine)
Kim Jae-Sung (Departments of Radiation Oncology, Institute on Radiation Medicine, Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine)
Park Charn Il (Departments of Radiation Oncology, Institute on Radiation Medicine, Medical Research Center, Seoul National University College of Medicine)
Kim In-Ah (Department of Radiation Oncology, Bundang Seoul National University Hospital)
Kim Kwang Hyun (Departments of Otorhinolarynogology and Head & Neck Surgery, Seoul National University College of Medicine)
Lee Chae Seo (Departments of Otorhinolarynogology and Head & Neck Surgery, Seoul National University College of Medicine)
Publication Information
Radiation Oncology Journal / v.23, no.3, 2005 , pp. 131-136 More about this Journal
Abstract
Purpose: The aim of this study was to evaluate the clinical results of postoperative radiotherapy for parotid gland malignancy, and determine prognostic factors for locoregional control and survival. Materials and Methods: Between 1980 and 2002, 130 patients with parotid malignancy were registered In the database of the Department of Radiation Oncology, Seoul National University Hospital. The subjects of this analysis were the 72 of these 130 patients who underwent postoperative Irradiation, There were 42 males and 30 females, with a median age of 46.5 years. The most common histological type was a mucoepidermoid carcinoma. There were 6, 23, 23 and 20 patients in Stages I, II, III and IV, respectively. The median dose to the tumor bed was 60 Gy, with a median fraction size of 1.8 Gy. Results: The overall 5 and 10 year survival rates were 85 and $76\%$, respectively, The five-year locoregional control rate was $85\%$, which reached a plateau phase after 6 years. Sex and histological type were found to be statistically significant for overall survival from a multivariate analysis. No other factors, Including age, facial nerve palsy and stage, were related to overall survival. For locoregional control, nodal involvement and positive resection margin were associated with poor local control. Histological type, tumor size, perineural invasion and type of surgery were not significant for locoregional control. Conclusion: A high survival rate of parotid gland malignancies, with surgery and postoperative radiotherapy, was confirmed. Sex and histological type were significant prognostic factors for overall survival. Nodal Involvement and a positive resection margin were associated with poor locoregional control.
Keywords
Parotid gland malignancy; Postoperative radiotherapy; Prognostic factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tu GY, Hu YH, Jiang PJ, et al. The superiority of combined therapy (surgery and postoperative irradiation) in parotid cancer. Arch Otolaryngol 1982;108:710-713   DOI
2 Kim WD, Park CI, Kim KH. Radiation therapy in malignant tumors of the parotid gland. J Korean Soc Ther Radiol 1994;12:43-49
3 Armstrong JG, Harrison LB, Spiro RH, et al. Observations on the natural history and treatment of recurrent major salivary gland cancer. J Surg Oncol 1990;44:138-141   DOI   ScienceOn
4 Poulsen MG, Tripcony LB, Kynaston B. Nodal recurrence in primary malignant epithelial tumours of the parotid gland. Australas Radio 1991;35:169-173   DOI   ScienceOn
5 Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992;164:623-628   DOI   ScienceOn
6 AJCC cancer staging manual. 6th ed. Greene FL. Page DL. Fleming ID, et al. Chicago; 2002:69-75
7 Garden AS, EL-Naggar AK, Morrison WH, et al. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 1997;37:79-85   DOI   ScienceOn
8 Hosokawa Y, Shirato H, Kagei K, et al. Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral oncology 1999;35:105-111   DOI   ScienceOn
9 Kelly DJ, Spiro RH. Management of the neck in parotid carcinoma. Am J Surg 1996;172:695-697   DOI   ScienceOn
10 Terhaard CHJ, Lubsen H, Rasch CRN, et al. The role of radiotherapy in the treatment of malignant parotid gland tumors. Int J Radiat Oncol Biol Phys 2005;61:103-111   DOI   ScienceOn
11 Korkmaz H, Yoo GH, Du W, et al. Predictors of nodal metastasis in salivary gland cancer. J Surg Oncol 2002;80: 186-189   DOI   ScienceOn
12 Simpson JR. Salivary glands. In : Perez PA, Brady LW, eds. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia, PA: Lippincott Co. 2004:976-977
13 Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992;69:615-619   DOI   PUBMED   ScienceOn
14 Terhaard CHJ, Lubsen H, Eijkenboom WMH, et al. Salivary gland carcinoma: independent prognostic factors of locoregional control, distant metastases, and survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004;26:681-693   DOI   ScienceOn
15 Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 1991;117:1251-1256   DOI   ScienceOn